Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 476 to 500

  • AusPAR: Reslizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Reslizumab

  • AusPAR: Tocilizumab (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tocilizumab (rch)

  • AusPAR: Obinutuzumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Obinutuzumab

  • AusPAR: Palbociclib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Palbociclib [Ibrance]

  • AusPAR: Ranolazine

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ranolazine

  • AusPAR: teduglutide

    Australian Public Assessment Report (AusPAR)
    Teduglutide [Revestive]

  • AusPAR: Phleum pratense

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Phleum pratense

  • AusPAR: Tamoxifen

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tamoxifen

  • AusPAR: Alectinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Alectinib

  • AusPAR: Ceritinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ceritinib [Zykadia]

  • AusPAR: Tolvaptan

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tolvaptan

  • AusPAR: Blinatumomab (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for blinatumomab (rch)

  • AusPAR: Blinatumomab (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Blinatumomab

  • AusPAR: Lonoctocog alfa (rch)

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Lonoctocog alfa (rch)

  • AusPAR: Sodium phenylbutyrate

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Sodium phenylbutyrate

  • AusPAR: Ofatumumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ofatumumab

  • AusPAR: Nitric oxide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for nitric oxide

  • AusPAR: Desmopressin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Desmopressin

  • AusPAR: Dapsone

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for dapsone

  • AusPAR: Everolimus

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Everolimus

Help us improve the Therapeutic Goods Administration site